| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2025 ( Subtotal = -$392,719 ) |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 000 | 5 | NIH | 11/13/2024 | $0 |
| | 2025 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 03 | 13 | HRSA | 10/17/2024 | $0 |
| | 2025 | 2024 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 04 | 13 | HRSA | 10/29/2024 | -$366,137 |
| | 2025 | 2023 | Old Dominion University | 735 Fairfax Ave Ste 909 | Norfolk | VA | 23507-2007 | NORFOLK CITY | USA | E3626086 | LDS - Allopathic Medicine | 001 | 3 | HRSA | 10/3/2024 | $0 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 001 | 1 | NIH | 10/23/2024 | $0 |
| | 2025 | 2023 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 002 | 1 | NIH | 10/23/2024 | $0 |
| | 2025 | 2020 | OLD DOMINION UNIVERSITY | 735 FAIRFAX AVE STE 909 | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01AG050567 | Histone H4 Lysine16 Acetylation in Aging and Lung Fibrosis | 000 | 6 | NIH | 10/27/2024 | -$26,582 |
|
| Issue Date FY: 2024 ( Subtotal = -$1,954,835 ) (Continued on the next page) |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 002 | 4 | NIH | 6/26/2024 | $34,801 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 002 | 5 | NIH | 9/13/2024 | -$87,651 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 000 | 5 | NIH | 2/15/2024 | $219,003 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 001 | 5 | NIH | 6/28/2024 | -$196,067 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01CA245716 | Using Differences in Perceived Legitimacy and Resident Compliance to Promote Fair and Effective Implementation of Smoke Free Housing | 000 | 5 | NIH | 6/3/2024 | $363,920 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 002 | 3 | NIH | 6/27/2024 | -$150,980 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL169253 | Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | 001 | 1 | NIH | 6/27/2024 | -$245,667 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 001 | 3 | NIH | 6/12/2024 | $45,349 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL169253 | Epigenetic Modulation of Cellular Senescence in the Cystic Fibrosis Lung | 000 | 1 | NIH | 3/15/2024 | $645,992 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL160966 | The mechanisms of cardiac thin filament regulation in health and disease. | 000 | 3 | NIH | 12/21/2023 | $510,187 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 01 | 13 | HRSA | 6/3/2024 | $323,437 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 00 | 13 | HRSA | 3/13/2024 | $107,811 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | H7624728 | Ryan White Part C Outpatient EIS Program | 02 | 13 | HRSA | 8/2/2024 | $11,507 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 000 | 5 | NIH | 12/6/2023 | $145,229 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | K01DK127150 | Osteopontin: A Novel Mediator of prostatic inflammation and fibrosis | 001 | 5 | NIH | 6/28/2024 | -$95,240 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 001 | 2 | NIH | 9/13/2024 | -$166,546 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA280570 | Developing glycosylated RNAs as novel clinical targets for aggressive prostate cancer. | 000 | 2 | NIH | 4/10/2024 | $166,547 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 003 | 4 | NIH | 6/28/2024 | -$95,543 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R00HD099269 | A-to-I RNA modifications in mouse oocytes | 001 | 5 | NIH | 5/2/2024 | $21,899 |
| | 2024 | 2024 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151702 | Bromodomain-containing Protein 4 in Profibrotic Gene Expression and Lung Fibrosis | 001 | 4 | NIH | 1/29/2024 | $404,053 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01DA054826 | Role of the NLRP3 Inflammasome in Mediating Microglial Activation and Development of Neuropsychiatric Symptoms Induced by HIV, Antiretrovirals and Cocaine | 000 | 3 | NIH | 6/28/2024 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 003 | 1 | NIH | 7/2/2024 | -$254,032 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 002 | 1 | NIH | 7/2/2024 | -$13,325 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R33AI142685 | Project Horizon: Hydrogel Injectable Depot System for Next-Generation Long-Acting HIV Prevention and Contraception | 000 | 5 | NIH | 9/4/2024 | -$1,986,389 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL150014 | Interleukin 12 disruption provides beta cell and microvessel protection in type 2diabetes | 000 | 4 | NIH | 6/27/2024 | -$73,063 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21HD112742 | Designing effective RNA therapies for oocyte maturation | 000 | 1 | NIH | 9/13/2024 | -$303,504 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Addressing Low-Income Housing Resident Mistrust in COVID-19 Guidance. | 002 | 4 | NIH | 6/12/2024 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Addressing Low-Income Housing Resident Mistrust in COVID-19 Guidance. | 001 | 4 | NIH | 6/11/2024 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Addressing Low-Income Housing Resident Mistrust in COVID-19 Guidance. | 000 | 4 | NIH | 12/5/2023 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA287457 | Does Tobacco Social Media Marketing Alter Adolescent Risk Perceptions and Use? Longitudinal Data-Adaptive Estimators and Causal Inference to Enhance Understanding | 003 | 1 | NIH | 9/26/2024 | $137,564 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21CA287457 | Does Tobacco Social Media Marketing Alter Adolescent Risk Perceptions and Use? Longitudinal Data-Adaptive Estimators and Causal Inference to Enhance Understanding | 000 | 1 | NIH | 7/15/2024 | -$174,022 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U2CCA271894 | Virginia-UCLA-Toronto Biomarker Characterization Center | 000 | 2 | NIH | 9/9/2024 | -$257,353 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01HL151616 | Stromal interaction molecule 1, immune cells, and vascular pathology in established hypertension | 000 | 4 | NIH | 6/27/2024 | -$16,879 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 000 | 1 | NIH | 11/20/2023 | $0 |
| | 2024 | 2023 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | U01MD018316 | Evaluating a Community-Led COVID-19 Testing Intervention to Address Mistrust | 001 | 1 | NIH | 11/20/2023 | $0 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01MH118139 | Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition | 001 | 4 | NIH | 12/15/2023 | -$372,119 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R37CA245716 | Addressing Low-Income Housing Resident Mistrust in COVID-19 Guidance. | 003 | 3 | NIH | 9/6/2024 | $0 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21ES033007 | Cannabinoid-2 receptor signaling in vesicant induced lung injury | 000 | 2 | NIH | 6/12/2024 | $0 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | F31NS116926 | Identification and characterization of a new pericyte subset: Role in blood-brain barrier breakdown | 000 | 3 | NIH | 5/22/2024 | -$3,805 |
| | 2024 | 2022 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R01MH118139 | Targeting SIV macrophage reservoirs in the CNS by CSF1R inhibition | 000 | 4 | NIH | 12/15/2023 | -$663,991 |
| | 2024 | 2021 | EASTERN VIRGINIA MEDICAL SCHOOL | 735 FAIRFAX AVE STE 909C | NORFOLK | VA | 23507-2007 | NORFOLK CITY | USA | R21AI145809 | An Aptamer-Based Biosensor for Point-of-Care Monitoring of Adherence to Oral Tenofovir Antiretroviral Regimens for HIV Prevention and Treatment | 000 | 2 | NIH | 1/8/2024 | -$272 |
|
